RecruitingStrokeChronic StrokeIntracerebral Haemorrhage
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
Sponsor: Johns Hopkins University
You may qualify if…
- ✓ Over age 18 years, inclusive.
- ✓ Ischemic or hemorrhagic stroke confirmed by CT or MRI, at least 12 months prior to admission date
- ✓ Ability to give informed consent and understand the tasks involved.
- ✓ Agree that, for the study duration, will refrain from: (1) No new prescription medications during the time of the study without approval of the study team, (2) taking any herbal supplement (except with prior approval of the research team), (3) taking any nonprescription medications with the exception of: 1. non-steroidal anti-inflammatory drugs. 2. acetaminophen. 3. vitamins. 4. or other over-the-counter medications approved by the research team
- ✓ Are willing to follow restrictions and guidelines concerning medications, consumption of food, beverages, and nicotine the night before and just prior to psilocybin administration.
- ✓ Agree to have transportation other than driving themselves home or to where the participants are staying after the administration of psilocybin.
- ✓ Are willing to be contacted via telephone for all necessary telephone contacts.
- ✓ Must have a negative pregnancy test if able to bear children.
You may not qualify if…
- ✕ Taking one of the following medications in the 30 days prior to psilocybin administration:
- ✕ 1. selective serotonin reuptake inhibitor (SSRI)
- ✕ 2. Serotonin-norepinephrine reuptake inhibitors (SNRI)
- ✕ 3. Buproprion
- ✕ 4. Valproic acid
- ✕ 5. Zolpidem
- ✕ 6. Trazodone
- ✕ 7. Carbamazepine.
Where it's recruiting
Maryland
Baltimore
Source: ClinicalTrials.gov · NCT07053917 · last updated 2026-02-13